Discontinuation report HIBERIX
Report ID | 175258 |
Drug Identification Number | 02239200 |
Brand name | HIBERIX |
Common or Proper name | Haemophilus influenzae type b (Hib) conjugate vaccine |
Company Name | GLAXOSMITHKLINE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE |
Strength(s) | 10MCG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | All pack sizes / Tous les formats |
ATC code | J07AG |
ATC description | BACTERIAL VACCINES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2023-03-24 |
Remaining supply date | 2023-06-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-03-29 | French | Compare |
v3 | 2023-03-29 | English | Compare |
v2 | 2022-11-18 | French | Compare |
v1 | 2022-11-18 | English | Compare |
Showing 1 to 4 of 4